Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS SALVO: FORMAS FARMACÉUTICAS QUE MODIFICAN LA LIBERACIÓN DEL PRINCIPIO ACTIVO |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 05.05. FÁRMACOS PARA EL DOLOR NEUROPÁTICO | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 05. ANTICONVULSANTS/ ANTIEPILEPTICS | No observations |
| PAHO Strategic Fund Medicine List | 12.1. Oxytocics |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| Peru | 05. Anticonvulsants/Antiepileptics | No observations |
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 03. ANTIEPILÉPTICOS | No observations |
| Guyana. Essential Medicines List. 2020-2021 | Other Anticonvulsants | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 28:12 Anti-convulsant agents | No observations |
| Haiti. National List of Essential Medicines | 05. Antiepileptics/ Anticonvulsants | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 28.12.92 Miscellaneous Anticonvulsants | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 04.06.03 Neuropathic Pain | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 04.07.01 Control of Epilepsy | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | N. SISTEMA NERVOSO | No observations |
| Bahamas. Drug Formulary | 05.01 Anticonvulsants | No observations |
| List | Section | Observation |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Cns Anticonvulsants-Miscellaneous | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 28. Anticonvulsivos | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 14. NEUROLOGIA | No observations |
| List | Section | Observation |
|---|---|---|
| Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 | 03 ANTIEPILÉPTICOS | No observations |
| List | Section | Observation |
|---|---|---|
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 02.01 ANTICONVULSANTS | No observations |
| List | Section | Observation |
|---|---|---|
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 02.01 ANTICONVULSANTS | No observations |
| Haiti. National List of Essential Medicines | 24.02.02 Normothymics | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 28.12.92 Miscellaneous Anticonvulsants | No observations |
| Bahamas. Drug Formulary | 05.01 Anticonvulsants | No observations |
| Belize. National Drug Formulary | 05. ANTICONVULSANTS/ ANTIEPILEPTICS | No observations |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 02.01 ANTICONVULSANTS | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 14. NEUROLOGIA | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | N. SISTEMA NERVOSO | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 04.06.03 Neuropathic Pain | No observations |
| List | Section | Observation |
|---|---|---|
| Haiti. National List of Essential Medicines | 05. Antiepileptics/ Anticonvulsants | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 05. ANTICONVULSANTS/ ANTIEPILEPTICS | No observations |
| PAHO Strategic Fund Medicine List | 12.1. Oxytocics | No observations |
| Suriname. NGK-C-011 | 05. Anti-Convulsants/ Anti-Epileptics | No observations |
| Suriname. NGK-C-011 | 25.3 Substances Used in Bipolar Disorder | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 05. ANTICONVULSANTS/ ANTIEPILEPTICS | No observations |
| PAHO Strategic Fund Medicine List | 12.1. Oxytocics | No observations |
| Suriname. NGK-C-011 | 05. Anti-Convulsants/ Anti-Epileptics | No observations |
| Suriname. NGK-C-011 | 25.3 Substances Used in Bipolar Disorder | No observations |
| List | Section | Observation |
|---|---|---|
| Barbados. Barbados National Drug Formulary (BNDF) | 28.12.92 Miscellaneous Anticonvulsants | No observations |
| Bahamas. Drug Formulary | 05.01 Anticonvulsants | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 04.07.01 Control of Epilepsy | No observations |
| List | Section | Observation |
|---|---|---|
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 28:12 Anti-convulsant agents | No observations |
| Bahamas. Drug Formulary | 05.01 Anticonvulsants | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 04.07.01 Control of Epilepsy | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 05. ANTICONVULSANTS/ ANTIEPILEPTICS | No observations |
| WHO Model List of Essential Medicines (2021) | 24.2.2. Medicines used in bipolar disorders | No observations |
| PAHO Strategic Fund Medicine List | 12.1. Oxytocics |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 05. ANTICONVULSANTS/ ANTIEPILEPTICS | No observations |
| WHO Model List of Essential Medicines (2021) | 24.2.2. Medicines used in bipolar disorders | No observations |
| PAHO Strategic Fund Medicine List | 12.1. Oxytocics |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| Peru | 05. Anticonvulsants/Antiepileptics | No observations |
| Peru | 24.2.2 For Bipolar Disorder | No observations |
| Guyana. Essential Medicines List. 2020-2021 | Other Anticonvulsants | No observations |
| Belize. National Drug Formulary | 24.02.02 Medicines used in bipolar disorders | No observations |
| List | Section | Observation |
|---|---|---|
| Guyana. Essential Medicines List. 2020-2021 | Other Anticonvulsants | No observations |